Global Single Cell Multi-Omics Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Single Cell Multi-Omics Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Single-cell multi-omics can analyze genome, epigenome, transcriptome, proteome, and metabolome lineages, unlike live-cell fluorescence imaging, which is a method of destroying cells for analysis.
Single Cell Multi-Omics report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Single Cell Multi-Omics market is projected to reach US$ 3485.8 million in 2034, increasing from US$ 1810.6 million in 2022, with the CAGR of 9.3% during the period of 2024 to 2034. Demand from Oncology and Cell Biology are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Single Cell Multi-Omics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Single Cell Multi-Omics key companies include 10x Genomics, 1CellBio, MissionBio, NanoString Technologies, Fluidigm Corporation, Fluxion Biosciences, Bio-Rad Laboratories, Celsee and BGI Genomics, etc. 10x Genomics, 1CellBio, MissionBio are top 3 players and held % share in total in 2022.
Single Cell Multi-Omics can be divided into Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics and Single Cell Metabolomics, etc. Single Cell Genomics is the mainstream product in the market, accounting for % share globally in 2022.
Single Cell Multi-Omics is widely used in various fields, such as Oncology, Cell Biology, Neurology and Immunology, etc. Oncology provides greatest supports to the Single Cell Multi-Omics industry development. In 2022, global % share of Single Cell Multi-Omics went into Oncology filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Single Cell Multi-Omics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
10x Genomics
1CellBio
MissionBio
NanoString Technologies
Fluidigm Corporation
Fluxion Biosciences
Bio-Rad Laboratories
Celsee
BGI Genomics
GE LifeSciences
Illumina
Takara Bio
QIAGEN N.V.
Segment by Type
Single Cell Genomics
Single Cell Proteomics
Single Cell Transcriptomics
Single Cell Metabolomics
Oncology
Cell Biology
Neurology
Immunology
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Single Cell Multi-Omics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Single Cell Multi-Omics introduction, etc. Single Cell Multi-Omics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Single Cell Multi-Omics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Single Cell Multi-Omics report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Single Cell Multi-Omics market is projected to reach US$ 3485.8 million in 2034, increasing from US$ 1810.6 million in 2022, with the CAGR of 9.3% during the period of 2024 to 2034. Demand from Oncology and Cell Biology are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Single Cell Multi-Omics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Single Cell Multi-Omics key companies include 10x Genomics, 1CellBio, MissionBio, NanoString Technologies, Fluidigm Corporation, Fluxion Biosciences, Bio-Rad Laboratories, Celsee and BGI Genomics, etc. 10x Genomics, 1CellBio, MissionBio are top 3 players and held % share in total in 2022.
Single Cell Multi-Omics can be divided into Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics and Single Cell Metabolomics, etc. Single Cell Genomics is the mainstream product in the market, accounting for % share globally in 2022.
Single Cell Multi-Omics is widely used in various fields, such as Oncology, Cell Biology, Neurology and Immunology, etc. Oncology provides greatest supports to the Single Cell Multi-Omics industry development. In 2022, global % share of Single Cell Multi-Omics went into Oncology filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Single Cell Multi-Omics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
10x Genomics
1CellBio
MissionBio
NanoString Technologies
Fluidigm Corporation
Fluxion Biosciences
Bio-Rad Laboratories
Celsee
BGI Genomics
GE LifeSciences
Illumina
Takara Bio
QIAGEN N.V.
Segment by Type
Single Cell Genomics
Single Cell Proteomics
Single Cell Transcriptomics
Single Cell Metabolomics
Segment by Application
Oncology
Cell Biology
Neurology
Immunology
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Single Cell Multi-Omics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Single Cell Multi-Omics introduction, etc. Single Cell Multi-Omics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Single Cell Multi-Omics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.